National Institute of Mental Health; Amended Notice of Meeting, 9164-9165 [2024-02652]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
9164
Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices
Service Act (42 U.S.C. 300aa–1), the
Secretary of HHS was mandated to
establish the National Vaccine Program
to achieve optimal prevention of human
infectious diseases through
immunization and to achieve optimal
prevention against adverse reactions to
vaccines. The NVAC was established to
provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
During this meeting, NVAC will hear
presentations to support the recent
charge on innovation from Admiral
Rachel L. Levine, MD, the Assistant
Secretary for Health and Director of the
National Vaccine Program. NVAC will
also hear presentations on recent surges
in measles cases, the Vaccines for
Children’s Program, real uses of
artificial intelligence to support
vaccination efforts, and supply chains.
Presenters will also cover ways to
improve immunization of children,
adults, and pregnant people. Please note
that agenda items are subject to change,
as priorities dictate. Information on the
final meeting agenda will be posted
prior to the meeting on the NVAC
website: https://www.hhs.gov/nvpo/
nvac/.
Members of the public will have the
opportunity to provide comment at the
NVAC meeting during the public
comment period designated on the
agenda. Public comments made during
the meeting will be limited to three
minutes per person to ensure time is
allotted for all those wishing to speak.
Members of the public may also submit
written comments. Written comments
should not exceed three pages in length.
Individuals planning to submit
comments should email their written
comments or their request to provide a
comment during the meeting to nvac@
hhs.gov at least five business days prior
to the meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 11, 2024.
Ann Aikin,
Acting Designated Federal Official, Office of
the Assistant Secretary for Health.
BILLING CODE 4140–01–P
[FR Doc. 2024–02636 Filed 2–8–24; 8:45 am]
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Study Section Digestive Diseases
and Nutrition C Study Section.
Date: March 13–15, 2024.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NIDDK
Democracy II, Suite 7000A, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7009,
Bethesda, MD 20892, (301) 594–4721,
kozelp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02697 Filed 2–8–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4150–44–P
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:20 Feb 08, 2024
Jkt 262001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Understudied Proteins
Associated with Rare Diseases (R03) Review.
Date: May 30, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892.
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Center for Advancing Translational
Sciences, National Institutes of Health, 6701
Democracy Boulevard, MSC 4874, Bethesda,
MD 20892, (301) 827–4312, ming.yan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: February 5, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02651 Filed 2–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Mental Health Special Emphasis Panel
BRAIN K99, March 6, 2024, 11:00 a.m.
to March 06, 2024, 6:30 p.m., National
Institutes of Health, Neuroscience
Center, 6001 Executive Boulevard,
Rockville, MD 20852 which was
published in the Federal Register on
February 2, 2024, FR Doc. 2024–02045,
89 FR 7403.
The meeting date has changed from
March 6, 2024, to March 15, 2024. The
E:\FR\FM\09FEN1.SGM
09FEN1
Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices
time of the meeting and the location
remain the same. The meeting is closed
to the public.
Dated: February 5, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Boulevard, Rockville, MD 20852, 301–496–
9223, bo-shiun.chen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: February 5, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02652 Filed 2–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–02654 Filed 2–8–24; 8:45 am]
BILLING CODE 4140–01–P
ddrumheller on DSK120RN23PROD with NOTICES1
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Center for Scientific Review; Notice of
Closed Meetings
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials and
Biomarker Studies in Stroke (StrokeNet).
Date: March 1, 2024.
Time: 9:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Nilkantha Sen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
9223, nilkantha.sen@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Collaborative Opportunities
for Multidisciplinary, Bold, and Innovative
Neuroscience (COMBINE) (RM1 Clinical
Trial Optional).
Date: March 7–8, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Bo-Shiun Chen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS, NSC, 6001 Executive
VerDate Sep<11>2014
18:36 Feb 08, 2024
Jkt 262001
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Cardiovascular Differentiation and
Development Study Section.
Date: March 6, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, (301) 435–0904, sara.
ahlgren@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiovascular Sciences.
Date: March 6, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Imoh S. Okon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–347–8881, imoh.okon@nih.gov.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
9165
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cancer and Hematologic Disorders Study
Section.
Date: March 7–8, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: EVEN Hotel Rockville, Previously
Holiday Inn, 1775 Rockville Pike, Rockville,
MD 20852.
Contact Person: Steven M. Frenk, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
Bethesda, MD 20892, (301) 480–8665,
frenksm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Imaging, Surgery and
Bioengineering.
Date: March 11, 2024.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, M.D., Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, 301–435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–21–
089: Specific Pathogen Free Macaque
Colonies.
Date: March 11, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Latha Malaiyandi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812Q,
Bethesda, MD 20892, (301) 435–1999,
malaiyandilm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Nucleic
Acid Therapeutic Delivery (NATD).
Date: March 12, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jingwu Xie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–8625, jingwu.xie@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurological and
Neuropsychological Injuries and Disorders.
Date: March 12, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 89, Number 28 (Friday, February 9, 2024)]
[Notices]
[Pages 9164-9165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02652]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Mental Health Special Emphasis Panel BRAIN K99, March 6,
2024, 11:00 a.m. to March 06, 2024, 6:30 p.m., National Institutes of
Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD
20852 which was published in the Federal Register on February 2, 2024,
FR Doc. 2024-02045, 89 FR 7403.
The meeting date has changed from March 6, 2024, to March 15, 2024.
The
[[Page 9165]]
time of the meeting and the location remain the same. The meeting is
closed to the public.
Dated: February 5, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02652 Filed 2-8-24; 8:45 am]
BILLING CODE 4140-01-P
